NMMC-Tupelo Receives Get With The Guidelines Target: Stroke Honor Roll Elite Plus Silver Quality Achievement Award
American Heart Association Award recognizes NMMC-Tupelo’s commitment to quality stroke care
Members of NMMC-Tupelo’s stroke team celebrated by watching the virtual awards presentation together in different locations to allow for social distancing.
TUPELO, Miss.—North Mississippi Medical Center-Tupelo has received the American Heart Association/American Stroke Association’s Get With The Guidelines® Target: Stroke Honor Roll Elite Plus Silver Quality Achievement Award. The award recognizes the hospital’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.
NMMC-Tupelo earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. Before discharge, patients should also receive education on managing their health and get a follow-up visit scheduled, as well as other care transition interventions.
“The mission of NMMC is to continuously improve the health of the people in our region. Unfortunately, we live in the Deep South where there are higher rates of stroke,” said David Wilson, NMMC-Tupelo president. “Fortunately, we have a highly qualified team of professionals who are improving the care of our stroke patients each and every day. Recognition by the American Heart Association’s Get With The Guidelines stroke initiative is evidence of this team’s dedication. This recognition was based on implementing evidence-based clinical guidelines and demonstrating a consistent and significant improvement in patient outcomes.”
NMMC-Tupelo additionally received the association’s Target: StrokeSM Honor Roll Elite award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.
“We are pleased to recognize NMMC-Tupelo for their commitment to stroke care,” said Lee H. Schwamm, M.D., national chairperson of the Quality Oversight Committee and Executive Vice Chair of Neurology, Director of Acute Stroke Services, Massachusetts General Hospital, Boston, Massachusetts. “Research has shown that hospitals adhering to clinical measures through the Get With The Guidelines quality improvement initiative can often see fewer readmissions and lower mortality rates.”
According to the American Heart Association/American Stroke Association, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds and nearly 795,000 people suffer a new or recurrent stroke each year.